Diagnostic accuracy of MRI/MRSI for patients with persistently high PSA levels and negative TRUS-guided biopsy results

Journal of the Medical Association of Thailand

Volumn 90, Issue 7, 2007, Pages 1391-1399

  Bhatia, Cathleeyakorn ^a   Phongkitkarun, Sith ^a   Booranapitaksonti, Dechaphol ^a   Kochakarn, Wachira ^a   Chaleumsanyakorn, Panas ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Magnetic resonance imaging; Prostate cancer; Spectroscopic imaging; Transrectal ultrasonography

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; HUMAN TISSUE; MALE; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROSPECTIVE STUDY; PROSTATE CANCER; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; TRANSRECTAL ULTRASONOGRAPHY; BIOPSY; ECHOGRAPHY; EVALUATION; INSTRUMENTATION; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROSTATE; PROSTATE TUMOR;

AGED; BIOPSY; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 34548543658     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Cancer in Thailand. Bangkok: Cancer Research Foundation for National Cancer Institute; 1995-1997.
2. Annual report ramathibodi cancer registry. Bangkok: Faculty of Medicine Ramathibodi Hospital Mahidol University; 2004.
3. Colombo T, Schips L, Augustin H, Gruber H, Hebel P, Petritsch PH, et al. Value of transrectal ultrasound in preoperative staging of prostate cancer. Minerva Urol Nefrol 1999; 51: 1-4.
4. Stamey TA. Making the most out of six systematic sextant biopsies. Urology 1995; 45: 2-12.
5. Ellis WJ, Brawer MK. Repeat prostate needle biopsy: who needs it? J Urol 1995; 153: 1496-8.
6. Zackrisson B, Aus G, Bergdahl S, Lilja H, Lodding P, Pihl CG, et al. The risk of finding focal cancer (less than 3 mm) remains high on re-biopsy of patients with persistently increased prostate specific antigen but the clinical significance is questionable. J Urol 2004; 171: 1500-3.
7. Prando A, Wallace S. Helical CT of prostate cancer: early clinical experience. AJR Am J Roentgenol 2000; 175: 343-6.
8. Perrotti M, Han KR, Epstein RE, Kennedy EC, Rabbani F, Badani K, et al. Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostastic biopsy: a pilot study. J Urol 1999; 162: 1314-7.
9. Beyersdorff D, Taupitz M, Winkelmann B, Fischer T, Lenk S, Loening SA, et al. Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging. Radiology 2002; 224: 701-6.
10. Scheidler J, Hricak H, Vigneron DB, Yu KK, Sokolov DL, Huang LR, et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging - clinicopathologic study. Radiology 1999; 213: 473-80.
11. Kurhanewicz J, Vigneron DB, Hricak H, Narayan P, Carroll P, Nelson SJ. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. Radiology 1996; 198: 795-805.
12. Yuen JS, Thng CH, Tan PH, Khin LW, Phee SJ, Xiao D, et al. Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy. J Urol 2004; 171: 1482-6.
13. Amsellem-Ouazana D, Younes P, Conquy S, Peyromaure M, Flam T, Debre B, et al. Negative prostatic biopsies in patients with a high risk of prostate cancer. Is the combination of endorectal MRI and magnetic resonance spectroscopy imaging (MRSI) a useful tool? A preliminary study. Eur Urol 2005; 47: 582-6.
14. Qayyum A, Coakley FV, Lu Y, Olpin JD, Wu L, Yeh BM, et al. Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging. AJR Am J Roentgenol 2004; 183: 1079-83.
15. Jung JA, Coakley FV, Vigneron DB, Swanson MG, Qayyum A, Weinberg V, et al. Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system. Radiology 2004; 233: 701-8.
16. Prando A, Kurhanewicz J, Borges AP, Oliveira EM Jr, Figueiredo E. Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience. Radiology 2005; 236: 903-10.
17. Males RG, Vigneron DB, Star-Lack J, Falbo SC, Nelson SJ, Hricak H, et al. Clinical application of BASING and spectral/spatial water and lipid suppression pulses for prostate cancer staging and localization by in vivo 3D 1H magnetic resonance spectroscopic imaging. Magn Reson Med 2000; 43: 17-22.